Prevalence of E2 Antibody Reactivity in Relation to Age in Patients With and Without HGV Viremia
| Year of Birth . | No. . | HGV-RNA Positive [95% CI]* HGV E2 ab Positive . | HGV-RNA Negative [95% CI] HGV E2 ab Positive . |
|---|---|---|---|
| Before 1950 | 30 | 2/4 (50%) [7-93%] | 25/26 (96%) [80-100%] |
| 1950-1959 | 30 | 0/6 (0%) [0-46%] | 19/24 (79%) [58-93%] |
| 1960-1969 | 30 | 1/11 (9%) [0-41%] | 14/19 (74%) [49-91%] |
| 1970-1979 | 30 | 3/10 (30%) [7-65%] | 10/20 (50%) [27-73%] |
| 1980-1989 | 30 | 1/16 (6%) [0-30%] | 6/14 (43%) [8-71%] |
| 1990-1993 | 19 | 0/2 (0%) [0-84%] | 0/17 (0%) [0-19%] |
| Total | 169 | 7/49 (14%) [6-27%] | 74/120 (62%) [52-70%] |
| Year of Birth . | No. . | HGV-RNA Positive [95% CI]* HGV E2 ab Positive . | HGV-RNA Negative [95% CI] HGV E2 ab Positive . |
|---|---|---|---|
| Before 1950 | 30 | 2/4 (50%) [7-93%] | 25/26 (96%) [80-100%] |
| 1950-1959 | 30 | 0/6 (0%) [0-46%] | 19/24 (79%) [58-93%] |
| 1960-1969 | 30 | 1/11 (9%) [0-41%] | 14/19 (74%) [49-91%] |
| 1970-1979 | 30 | 3/10 (30%) [7-65%] | 10/20 (50%) [27-73%] |
| 1980-1989 | 30 | 1/16 (6%) [0-30%] | 6/14 (43%) [8-71%] |
| 1990-1993 | 19 | 0/2 (0%) [0-84%] | 0/17 (0%) [0-19%] |
| Total | 169 | 7/49 (14%) [6-27%] | 74/120 (62%) [52-70%] |
Abbreviation: ab, antibody.
95% CI = 95% confidence interval.